| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a727fc8ed43cc6e479daaf2f04853df |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2000-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2c0d1ed3703b556dcb41458c1e93a27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86309695643f7ca015e05e4cf3debd3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37d4a5856647eb4754a169ccb8c4840f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_057a6b78897749c354c8f6ff974b1e2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ade9a2fcce12370ad41735c902333282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66159246dd78ab3a871e4a223c0cf3fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d35bd095d3db77a0830a53463e02459 |
| publicationDate |
2000-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0052179-A2 |
| titleOfInvention |
Dna binding compound-mediated molecular switch system |
| abstract |
The present invention provides molecular switch system methods and compositions for use in regulatable gene expression. The system includes a nucleic acid construct which has a DNA response sequence for a transcriptional regulatory protein operably linked to a promoter, a compound binding sequence in the vicinity of the DNA response sequence, a transgene under the control of the promoter; and a DNA binding compound. In some cases, the molecular switch system further includes a nucleic acid sequence encoding a transcriptional regulatory protein operably linked to a second promoter. The invention further provides a method for screening compounds for the ability to function in the molecular switch system and thereby regulate gene expression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0153479-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0153479-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0194600-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248195-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0248195-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0194600-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006051127-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6838556-B2 |
| priorityDate |
1999-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |